These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9854502)

  • 21. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity.
    Bickels J; Manusama ER; Gutman M; Eggermont AM; Kollender Y; Abu-Abid S; Van Geel AN; Lev-Shlush D; Klausner JM; Meller I
    Eur J Surg Oncol; 1999 Oct; 25(5):509-14. PubMed ID: 10527599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats.
    van der Veen AH; Seynhaeve AL; Breurs J; Nooijen PT; Marquet RL; Eggermont AM
    Br J Cancer; 1999 Feb; 79(3-4):433-9. PubMed ID: 10027309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha.
    Grünhagen DJ; de Wilt JH; van Geel AN; Eggermont AM
    Eur J Surg Oncol; 2006 May; 32(4):371-80. PubMed ID: 16520016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
    Hayes AJ; Neuhaus SJ; Clark MA; Thomas JM
    Ann Surg Oncol; 2007 Jan; 14(1):230-8. PubMed ID: 17066234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS;
    J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
    Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
    In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated limb perfusion: the European experience.
    Lejeune FJ; Kroon BB; Di Filippo F; Hoekstra HJ; Santinami M; Liénard D; Eggermont AM
    Surg Oncol Clin N Am; 2001 Oct; 10(4):821-32, ix. PubMed ID: 11641093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
    Rossi CR; Mocellin S; Pilati P; Foletto M; Campana L; Quintieri L; De Salvo GL; Lise M
    Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha.
    Laurenzi L; Natoli S; Di Filippo F; Calamaro A; Centulio F; Anzà M; Cavaliere F; Marcelli ME; Garinei R; Arcuri E
    J Exp Clin Cancer Res; 2004 Jun; 23(2):225-31. PubMed ID: 15354406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs.
    van Ijken MG; de Bruijn EA; de Boeck G; ten Hagen TL; van der Sijp JR; Eggermont AM
    Ann Surg; 1998 Dec; 228(6):763-70. PubMed ID: 9860475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma.
    Nachmany I; Subhi A; Meller I; Gutman M; Lahat G; Merimsky O; Klausner JM
    Eur J Surg Oncol; 2009 Feb; 35(2):209-14. PubMed ID: 18295442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated limb perfusion of soft tissue sarcomas: a comprehensive review of literature.
    Seinen JM; Hoekstra HJ
    Cancer Treat Rev; 2013 Oct; 39(6):569-77. PubMed ID: 23232098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.
    Grünhagen DJ; van Etten B; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM
    Ann Surg Oncol; 2005 Aug; 12(8):609-15. PubMed ID: 15968498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
    Rothbarth J; Tollenaar RA; Schellens JH; Nortier JW; Kool LJ; Kuppen PJ; Mulder GJ; van de Velde CJ
    Eur J Cancer; 2004 Aug; 40(12):1812-24. PubMed ID: 15288282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
    Di Filippo F; Garinei R; Anzà M; Cavaliere F; Giannarelli D; Cagol PP; Rossi CR; Santinami M; Deraco M; Botti C; Perri P; Di Filippo S; Piarulli L; Bruno P
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma-bearing rats.
    Hoving S; Brunstein F; aan de Wiel-Ambagtsheer G; van Tiel ST; de Boeck G; de Bruijn EA; Eggermont AM; ten Hagen TL
    Cancer Res; 2005 May; 65(10):4300-8. PubMed ID: 15899822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The past decade of experience with isolated hepatic perfusion.
    Grover A; Alexander HR
    Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.
    Thijssens KM; van Ginkel RJ; Pras E; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2006 Apr; 13(4):518-24. PubMed ID: 16485147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isolated extremity perfusion with TNF-alpha and melphalan in unresectable soft tissue sarcoma. Indications, principles and technique].
    Taeger G; Ruchholtz S; Niebel W; Müller S; Nast-Kolb D
    Unfallchirurg; 2004 Jul; 107(7):619-23. PubMed ID: 15252711
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors.
    Rothbarth J; Tollenaar RA; van de Velde CJ
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):553-65. PubMed ID: 16613543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.